Pure Global

In vitro reagents for new pregnancy tests - Taiwan Registration de5057580caf92fbad04880dbabace75

Access comprehensive regulatory information for In vitro reagents for new pregnancy tests in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number de5057580caf92fbad04880dbabace75 and manufactured by Longteng Biotech Co., Ltd. Xinshi Plant;; Liguo Pharmaceutical Co., Ltd. The authorized representative in Taiwan is Liguo Pharmaceutical Co., Ltd.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
de5057580caf92fbad04880dbabace75
Registration Details
Taiwan FDA Registration: de5057580caf92fbad04880dbabace75
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

In vitro reagents for new pregnancy tests
TW: ๆ–ฐๆƒ…้ฉ—ๅญ•้ซ”ๅค–่ฉฆๅŠ‘
Risk Class 2

Registration Details

de5057580caf92fbad04880dbabace75

Company Information

Product Details

This product qualitatively detects human chorionic gonadotropins in human urine.

A Clinical chemistry and clinical toxicology

A.1155 Human chorionic gonadotropin testing system

Domestic;; Contract manufacturing

Dates and Status

Apr 10, 2019

Oct 26, 2028